New Pathways in the Treatment of DMD
Erika Finanger, MD, MS
Aravindhan Veerapandiyan, MD
Implementing the Latest Diagnostic and Treatment Approaches for Generalized Myasthenia Gravis
Pushpa Narayanaswami, MD, FAAN
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape
Stephen Chrzanowski, MD, PhD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD
Jonathan M. Meyer
Advances in Managing Neuropsychiatric Symptoms of Alzheimer’s Disease: From Early Detection to Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Advancing Care: Clinical Innovations on the Horizon
John Vissing, MD, DMSci
Optimizing Patient Management Strategies
Integrating Perspectives: The Value of Patient and Caregiver Input
Conrad Weihl, MD, PhD
Navigating the LGMD2I/R9 Diagnostic Pathway
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
Raman Sankar, MD, PhD
Scott Aaronson, MD
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Epilepsy: Beyond Seizure Impact
New Frontiers in the Treatment of DMD Across the Age Spectrum
Crystal Proud, MD
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Charles P. Vega, MD
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Jerome A. Barakos, MD
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.